|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Carbapenemase Resistance Screen
Test CodeLAB5016 1230000186
Alias/See Also
CARBAPENEM RESISTENCE
CARBRP
CARBRP
CPT Codes
87150
Includes
CARBAPENEM RESISTANCE
IMIPENEMASE
VERONA INTEGRON MEDIATED
CLASS D OXACILLINASE
CKPC
NEW DELHI MBL
IMIPENEMASE
VERONA INTEGRON MEDIATED
CLASS D OXACILLINASE
CKPC
NEW DELHI MBL
Preferred Specimen
Perirectal swab
Instructions
Transport Container
STERILE SWAB
Transport Temperature
Room Temperature
Specimen Stability
Reference Range
| External Name | Result Checking Type | Values (C/S) |
| Carbapenem Resistance | Reference Range | Not Detected [4] |
| CKPC | Reference Range | Not Detected [4] |
| Class D Oxacillinase | Reference Range | Not Detected [4] |
| Imipenemase | Reference Range | Not Detected [4] |
| New Delhi MBL | Reference Range | Not Detected [4] |
| Verona Integron Mediated | Reference Range | Not Detected [4] |
Clinical Significance
The Xpert® CarbaR Assay, performed on the GeneXpert® Instrument System, is a qualitative in-vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48, and blaIMP gene sequences associated with carbapenem-non-susceptibility. The test utilizes automated real-time polymerase chain reaction (PCR). The assay is performed on rectal swab specimens from patients at risk for intestinal colonization with carbapenem-non-susceptible bacteria.
The Xpert CarbaR Assay is intended as an aid to infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The Xpert CarbaR Assay is not intended to guide or monitor treatment for carbapenem- non-susceptible bacterial infections.
A negative Xpert CarbaR Assay result does not preclude the presence of other resistance mechanisms. Other mechanisms of carbapenem resistance, including carbapenemase's not targeted by this assay, porin mutations, and hyperexpression of drug efflux pumps, may result in carbapenem resistance.
The Xpert CarbaR Assay is intended as an aid to infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings. The Xpert CarbaR Assay is not intended to guide or monitor treatment for carbapenem- non-susceptible bacterial infections.
A negative Xpert CarbaR Assay result does not preclude the presence of other resistance mechanisms. Other mechanisms of carbapenem resistance, including carbapenemase's not targeted by this assay, porin mutations, and hyperexpression of drug efflux pumps, may result in carbapenem resistance.
Performing Laboratory
MWH LAB
